Cardiogen, 20mg
$63.95
Cardiogen is a synthetic bioregulatory peptide under investigation for its activity in cardiac and prostate tissue models. Research interest centers on its proposed influence on molecular pathways associated with cardiovascular function and cellular regulation, including preliminary models of cardiovascular stress… Formula: C18H31N7O9 | Content: 20mg per vial | Research use only | Third-party lab tested.
Buy Cardiogen, 20mg – Swiss Chems USA
Cardiogen, 20mg — Research Overview
Cardiogen is a synthetic bioregulatory peptide under investigation for its activity in cardiac and prostate tissue models. Research interest centers on its proposed influence on molecular pathways associated with cardiovascular function and cellular regulation, including preliminary models of cardiovascular stress such as myocardial injury and hypertension. Research applications include cardiac tissue bioregulator studies, fibroblast pathway research, and comparative bioregulatory peptide pharmacology.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Cardiogen, 20mg Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C18H31N7O9 |
| Synonyms | SCHEMBL3194515 |
| Molar Mass | 489.5 g/mol |
| PubChem CID | 11583989 |
| Total Compound Content | 20mg per vial |
| Shelf Life | 36 months |
Cardiogen, 20mg Research Applications
Cardiogen is studied within the bioregulatory peptide research framework for its proposed activity in cardiac tissue, with experimental models examining its influence on fibroblast regulation and cellular pathways relevant to myocardial stress response. Preliminary studies have explored its potential relevance in models of cardiovascular stress, including myocardial injury and hypertension paradigms in animal research models. Cardiogen is also studied for possible synergistic interactions when combined with other compounds in experimental settings, positioning it within comparative bioregulatory peptide research examining cardiac tissue-specific signalling pathways. Independently third-party HPLC-tested; COA available per batch.
Cardiogen, 20mg Frequently Asked Questions
What research models are used to study Cardiogen’s proposed effects on cardiac fibroblast regulation?
In vitro cardiac fibroblast cultures are used to examine Cardiogen’s effects on fibroblast proliferation, migration, and extracellular matrix-related gene expression, readouts relevant to cardiac tissue remodelling research following injury. Ex vivo cardiac tissue explant models and rodent myocardial injury paradigms (such as ischemia-reperfusion models) are used as complementary systems to study fibroblast-related endpoints in the context of an intact tissue environment rather than isolated cell culture alone.
How is Cardiogen studied within preclinical models of cardiovascular stress such as myocardial injury?
Rodent models of myocardial injury (including surgically induced ischemia-reperfusion) and hypertension (using pharmacological or surgical induction methods) are standard preclinical systems for studying Cardiogen’s effects on cardiovascular stress-response pathways. Typical endpoints include cardiac functional measures (echocardiography-derived ejection fraction, fractional shortening), histological assessment of fibrosis or tissue damage, and molecular markers of stress-response signalling pathways in cardiac tissue samples.
What experimental approaches investigate Cardiogen’s potential synergistic effects with other research compounds?
Combination studies typically pair Cardiogen with other bioregulatory peptides or cardiovascular research compounds in the same cell-based or rodent model system, comparing combined treatment effects against each compound administered individually to determine whether observed effects are additive, synergistic, or independent. This comparative experimental design is standard practice for characterising potential interaction effects between bioregulatory peptides studied for overlapping or complementary tissue-specific activity.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
Related products
Reviews
There are no reviews yet.